These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1079955)

  • 61. Regarding the double-negative T cells in patients with systemic sclerosis.
    Zhang Q; Huang Y
    Clin Rheumatol; 2024 Jul; 43(7):2361. PubMed ID: 38739313
    [No Abstract]   [Full Text] [Related]  

  • 62. Inflammatory disease: T cell-targeted antibody reverses fibrosis.
    Crunkhorn S
    Nat Rev Drug Discov; 2016 Aug; 15(8):530-1. PubMed ID: 27444224
    [No Abstract]   [Full Text] [Related]  

  • 63. Genetic and environmental factors in scleroderma.
    Briggs DC; Welsh KI
    Curr Opin Rheumatol; 1989 Dec; 1(4):475-8. PubMed ID: 2702048
    [No Abstract]   [Full Text] [Related]  

  • 64. Protein status in long-stay geriatric in-patients.
    Banerjee AK; Brocklehurst JC; Swindell R
    Gerontology; 1981; 27(3):161-6. PubMed ID: 6786959
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comment on B lymphocytes in systemic sclerosis: Abnormalities and therapeutic targets.
    Chen Y; Liu J
    J Dermatol; 2017 Dec; 44(12):e367-e368. PubMed ID: 28771791
    [No Abstract]   [Full Text] [Related]  

  • 66. Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma).
    Kondo H; Rabin BS; Rodnan GP
    J Clin Invest; 1976 Dec; 58(6):1388-94. PubMed ID: 791970
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lymphocyte subpopulations and reactivity to mitogens in patients with scleroderma.
    Baron M; Keystone EC; Gladman DD; Lee P; Poplonski L
    Clin Exp Immunol; 1981 Oct; 46(1):70-6. PubMed ID: 6978216
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Circulating T and B lymphocytes in progressive systemic sclerosis.
    de Jesus DG; Clancy RL
    J Rheumatol; 1975 Sep; 2(3):336-9. PubMed ID: 1081143
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Stimulation of lymphocyte reactivity by a low molecular weight cutaneous antigen in patients with progressive systemic sclerosis (scleroderma).
    Kondo H; Rabin BS; Rodnan GP
    J Rheumatol; 1979; 6(1):30-7. PubMed ID: 374734
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [In vitro reactivity of lymphocytes obtained from patients with diffuse scleroderma].
    Onisk Z; Tchórzewski H
    Przegl Dermatol; 1975; 62(2):183-6. PubMed ID: 1079955
    [No Abstract]   [Full Text] [Related]  

  • 71. [Disorders of cellular immunity in systemic scleroderma].
    Sierakowski SJ; Kucharz EJ
    Przegl Lek; 1988; 45(7):592-7. PubMed ID: 3070641
    [No Abstract]   [Full Text] [Related]  

  • 72. Mechanisms of Disease: the role of immune cells in the pathogenesis of systemic sclerosis.
    Sakkas LI; Chikanza IC; Platsoucas CD
    Nat Clin Pract Rheumatol; 2006 Dec; 2(12):679-85. PubMed ID: 17133253
    [TBL] [Abstract][Full Text] [Related]  

  • 73. B lymphocyte function in patients with rheumatoid arthritis: impact of regulatory T lymphocytes and macrophages--modulation by antirheumatic drugs.
    Petersen J
    Dan Med Bull; 1988 Apr; 35(2):140-57. PubMed ID: 3282810
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Scleroderma. A model for fibrosis.
    Fleischmajer R; Perlish JS; Duncan M
    Arch Dermatol; 1983 Dec; 119(12):957-62. PubMed ID: 6360053
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.